Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc. ...Middle East

SEOUL, South Korea, May 30, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc. ("Rosvivo"), an American new drug developer, for about 5.5 million U.S. dollars. As a...

Hence then, the article about nexturn bio inc acquired a 50 stake in rosvivo therapeutics inc was published today ( Sunday 30/05/2021 - 05:55 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc. )

Also on site :

• Teens arrested after large disturbance, multiple fights at Joliet mall
• Transcript: Bank of America CEO Brian Moynihan on "Face the Nation with Margaret Brennan," Dec. 28, 2025
• Feel Free customers say the kratom drink is making them sick. Toothless FDA rules on dietary supplements are helping it remain a bestseller